Peptide Decoding
New?New to peptides?Start here →
Decoding

Tamoxifen_Dosage, benefits & legal status

Also known as tamoxifen citrate, Nolvadex, Soltamox, Nolva

Published August 24, 2026 · Updated October 5, 2026

A breast cancer drug with a boxed warning, sold as a gyno fix.

Estrogen blockingSERM (oral, not a peptide)FDA-approvedNot a peptideHigh-risk
Dose20 up to 40 mg per day
FrequencyDaily
RouteBy mouth (oral)
StatusFDA-approved
CycledContinuous, for years at a time in the trials

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Tamoxifen?

Plain language first. The technical label stays, but it never stands alone.

Overview

It blocks estrogen where breast tissue would respond to it, which is why it is used against breast cancer and against breast tissue growth in men.

The technical version

Tamoxifen is a selective estrogen receptor modulator that blocks estrogen in breast tissue while acting like estrogen in bone and the uterus.

What it's used for

A long-established breast cancer drug used on the research market to prevent or reverse breast tissue growth in men.

02

How does Tamoxifen work?

What it does in the body, and where.

Tamoxifen does not lower estrogen. It changes what estrogen is able to do, and the answer differs by tissue.

  1. 01
    It occupies the estrogen receptor
    Circulating estrogen is unchanged. The receptor is what is blocked.
  2. 02
    In breast tissue it acts as an antagonist
    This is the effect people are after, whether against a tumor or against breast tissue growth in men.
  3. 03
    In the uterus and bone it acts more like estrogen
    The bone effect is protective. The uterine effect is why the boxed warning names endometrial cancer and uterine sarcoma.
  4. 04
    It also raises clotting risk
    Stroke and pulmonary embolism sit in the boxed warning alongside uterine cancer.
Pathway
THE PEPTIDE
Tamoxifen
ACTS ON
Estrogen receptors, blocked in breast tissue
RESULT
Estrogen signaling drops in breast tissue
RESULT
Estrogen-like signaling continues in bone and uterus

A schematic of the compound's mechanism, not a diagnostic image.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Treating hormone receptor-positive breast cancerFDA-approved
  • Reducing breast cancer risk in high-risk women and after DCISFDA-approved
  • Preventing or reversing gynecomastia in men, off-labelClinical use
  • Restarting the hormone axis after a testosterone or anabolic cycleResearch only

The published record

Research index

29,758

Papers and trials about Tamoxifen

383 papers tagged human · 245 not reviews or lab · 51 clinical trial publications

684 registered trials · 19 with posted results

Furthest stage reached: Approved in the US

Compare this against the whole library →

Prohibited at all times, in and out of competition. S4.2 Anti-estrogenic substances (tamoxifen named). Specified Substance.Regulators
In animals126
In the lab7
Reviews48
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 501 papers and 100 trials indexed in detail.

Tamoxifen vial rendering
Compound field notes

At a glance

Four things to know about Tamoxifen

01

Evidence

FDA-approved

02

Category

Sexual and hormonal

03

Common vial

Varies

04

Half-life

5 to 7 days

04

How much, and do you cycle it?

The range, and whether you take breaks.

20 up to 40 mg per day, daily. Continuous, for years at a time in the trials FDA label

The risk-reduction indication runs 20 mg daily for five years without a break, and the adjuvant use runs for years. Nothing in the evidence base supports the short on-and-off courses used after an anabolic cycle, and nothing in it measures what those courses do.

Source: Soltamox prescribing information, DailyMed

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

5 to 7 daysFDA label

Tamoxifen itself declines in two phases with a terminal half-life of 5 to 7 days. Its main metabolite, N-desmethyl tamoxifen, runs about 14 days, which is why steady state takes 4 weeks for the parent and 8 weeks for the metabolite.

Source: Nolvadex label, Clinical Pharmacology

You can compare this against the whole library to see where it sits.

06

What does it cost?

Typical dose and cost, in plain numbers.

Tamoxifen is not injected

It is taken by mouth (oral). The label uses 20 to 40 mg daily depending on the indication, with 20 mg daily for five years in the risk-reduction setting, and doses above 20 mg split into a morning and evening dose. The doses used against gynecomastia sit inside this range but the indication does not exist on the label.

Cost per month
—
Cost per dose
—
Typical dose
20 mg–40 mg / dayFDA label
What it costs

Tamoxifen starts at $29.97 across 4 vendors, typically $5.50 per mg.

5 listings, last read Oct 10, 2026. Shipping and card fees are not included.

See all 5 listings →
07

How do you store it?

Before mixing, and after.

Room temperature. Cool, dry, out of light.

Tamoxifen is taken as a pill or capsule. Keep it in its original container at room temperature, away from heat, humidity, and direct sun. No fridge or mixing needed. Check the expiration date on the bottle.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Taking warfarin, if the reason for treatment is breast cancer risk reduction
  • A history of deep vein thrombosis or pulmonary embolism, in the same setting
  • Pregnancy
  • Known hypersensitivity to tamoxifen
  • Banned in drug-tested sport

Stop and get help

These are emergencies. Seek care.
  • Sudden shortness of breath, chest pain, or swelling and pain in one leg
  • Weakness or numbness on one side, trouble speaking, or a sudden severe headache
  • Abnormal vaginal bleeding, in anyone with a uterus
  • Yellowing of the skin or eyes
  • Signs of an allergic reaction such as face or throat swelling, hives, or trouble breathing

Common effects

Expected, and usually mild.
  • Hot flushes
  • Fluid retention
  • Nausea
  • Mood changes
  • Reduced libido
  • Changes in vision, including cataract formation over time

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Tamoxifen approved?

And where the numbers on this page come from.

Yes. Tamoxifen is FDA approved and available on prescription in the United States.

What has happened recently

First approved in the US in 1977. The label carries a boxed warning: serious, life-threatening and fatal events including uterine cancer, stroke and pulmonary embolism, applied to women taking it to reduce breast cancer risk or after DCIS. In the NSABP P-1 prevention trial the rate of endometrial adenocarcinoma was 2.20 per 1,000 women-years against 0.71 on placebo, and pulmonary embolism 0.75 against 0.25. In that same risk-reduction setting the label makes it a contraindication to take warfarin or to have a history of deep vein thrombosis or pulmonary embolism. Prohibited in sport at all times by WADA under section S4.

What regulators say

From official documents

Banned in drug-tested sport. Most research peptides are prohibited under WADA's S0 category, which covers any substance with no approval from any regulatory authority for human use. That means a compound can be banned without ever being named on the prohibited list. Check with your own anti-doping authority rather than assuming absence from the list means permitted.

You can compare this against the whole library, or read how to check a seller.

Guides for this compound

Sources

Beyond these, 601 records are indexed. Browse the records